David Hong, MD of MD Anderson Cancer Center @MDAndersonNews discusses at this year’s virtual AACR the efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations.
David Hong, MD on Outcomes of Larotrectinib in Patients with Cancer and NTRK Gene Fusions @MDAndersonNews #AACR2020
